Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study von Mazereeuw, Graham, Herrmann, Nathan, Xu, Hongbin, Blanchard, Alexandre P, Figeys, Daniel, Oh, Paul I, Bennett, Steffany Al, Lanctôt, Krista L

Volltext

The health status of obese individuals in Canada von TRAKAS, K, OH, P. I, SINGH, S, RISEBROUGH, N, SHEAR, N. H

Volltext

COST‐EFFECTIVENESS AND CARDIOVASCULAR RISK—AN ANALYSIS OF ROSIGLITAZONE COMPARED WITH OTHER ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS von Oh, Pi, Shane, Lg

Volltext

Economic Evaluation of Oseltamivir Phosphate for Postexposure Prophylaxis of Influenza in Long-Term Care Facilities von Risebrough, Nancy A., Bowles, Susan K., Simor, Andrew E., McGeer, Alison, Oh, Paul I.

Volltext

HT2 HEALTH TECHNOLOGY ASSESSMENT – A COMPREHENSIVE FRAMEWORK FOR EVIDENCE-BASED RECOMMENDATIONS IN ONTARIO von Johnson, A, Sikich, N, Evans, G, Evans, W, Giacomini, M, Glendining, M, Krahn, MD, Levin, L, Oh, PI, Perera, C

Volltext

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes von OH, PAUL I, LANCTÔT, KRISTA L, YOON, ALICE, LEE, DAVID S. C, PAES, BOSCO A, SIMMONS, BRIAN S, PARISON, DIANA, MANZI, PATRICIA

Volltext

Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: Impact of bioavailability on costs and outcomes von MITTMANN, Nicole, OH, Paul I, WALKER, Scott E, BARTLE, William R

Volltext

A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children von Oh, Paul I., Maerov, Phillip, Pritchard, Daniel, Knowles, Sandra R., Einarson, Thomas R., Shear, Neil H.

Volltext

The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: A willingness-to-pay approach von WU, Grace, LANCTOT, Krista L, HERRMANN, Nathan, MOOSA, Shehnaz, OH, Paul I

Volltext

PDB4: COST-EFFECTIVENESS AND CARDIOVASCULAR RISK—AN ANALYSIS OF ROSIGLITAZONE COMPARED WITH OTHER ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS von Oh, PI, Shane, LG

Volltext

ASSESSING LIFESTYLE DRUGS FOR DRUG BENEFIT FORMULARIES: A COST‐UTILITY ANALYSIS OF ORLISTAT AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN ADULTS von Trakas, K, Oh, Pi, Leiter, L, Shear, Nh

Volltext

Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic von Phillips, E, Louie, M, Knowles, SR, Simor, AE, Oh, PI

Volltext

PWP4: A WILLINGNESS-TO-PAY ASSESSMENT OF TWO TREATMENTS FOR OBESITY von Trakas, K, Oh, PI, Shear, NH

Volltext

Holistic versus Composite Preferences for Lifetime Treatment Sequences for Type 2 Diabetes von Mackeigan, Linda D., O'Brien, Bernie J., Oh, Paul I.

Volltext

HP4: ASSESSING LIFESTYLE DRUGS FOR DRUG BENEFIT FORMULARIES: A COST-UTILITY ANALYSIS OF ORLISTAT AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN ADULTS von Trakas, K, Oh, PI, Leiter, L, Shear, NH

Volltext

Quantifying the Costs of Serious Adverse Drug Reactions to Antiepileptic Drugs von Schlienger, Raymond G., Oh, Paul I., Knowles, Sandra R., Shear, Neil H.

Volltext

D4: ECONOMIC ANALYSIS OF WARFARIN IN OUTPATIENTS WITH ATRIAL FIBRILLATION: INNOVATOR VERSUS GENERIC von Mittmann, N, Bartle, W, Walker, SE, Oh, PI

Volltext

PMT21: DERIVING HEALTH UTILITIES FROM EFFICACY OUTCOME SCALES IN ALZHEIMER'S DISEASE (AD) von Lanctot, KL, Oh, PI, Risebrough, N, Mazzotta, P

Volltext

PID14: ECONOMIC ANALYSIS OF ANTIMICROBIAL AGENTS FOR HOSPITAL-ACQUIRED PNEUMONIA von Wong, AH, Oh, PI, Shear, NH

Volltext

Antidepressant Selection, Healthcare Resource Consumption and Costs in a Large Workplace Environment: US and Canadian Perspectives von Optenberg, Scott A., Lanct??t, Krista L., Herrmann, Nathan, Oh, Paul I.

Volltext